Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1980 Jan 1;151(1):81–90. doi: 10.1084/jem.151.1.81

Induction of acute cholecystitis by activation of factor XII

PMCID: PMC2185753  PMID: 6765972

Abstract

Acute, acalculous cholecystitis is seen among patients suffering with bacterial sepsis, burns, trauma, or cancer; clinical conditions that could lead to activation of factor XII-dependent pathways and result in inflammation of the gall bladder. To test this hypothesis, dogs were injected intravenously with ellagic acid or rutin, known polyphenol activators of factor XII, or with Escherichia coli endotoxin, also known to activate factor XII, and monkeys were injected intravenously with ellagic acid. In both species, in vivo activation of factor XII- dependent pathways with polyphenol activator resulted in rapid and selective development of acute vasculitis in the serosa and muscularis of the gallbladder and margination of polymorphonuclear neutrophils in pulmonary blood vessels. Intravenous injection of E. coli endotoxin in dogs resulted in necrosis and thrombosis of vessels that were especially severe in the serosa and muscularis of the gallbladder but also present in vessels of many other organs. These observations indicate that blood vessels of the gall bladder and, to a lesser degree, the lung are especially sensitive to injury consequent to in vivo activation of factor XII-dependent pathways and, in view of the common ingestion of plant polyphenols, may provide important insight into the pathogenesis of cholecystitis in man.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOTTI R. E., RATNOFF O. D. STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID. J Lab Clin Med. 1964 Sep;64:385–398. [PubMed] [Google Scholar]
  2. Becker C. G., Dubin T. Activation of factor XII by tobacco glycoprotein. J Exp Med. 1977 Aug 1;146(2):457–467. doi: 10.1084/jem.146.2.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bokisch V. A., Müller-Eberhard H. J., Cochrane C. G. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med. 1969 May 1;129(5):1109–1130. doi: 10.1084/jem.129.5.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colman R. W. Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun. 1969 Apr 29;35(2):273–279. doi: 10.1016/0006-291x(69)90278-2. [DOI] [PubMed] [Google Scholar]
  5. Friberger P., Knös M., Gustavsson S., Aurell L., Claeson G. Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis. 1978;7(2-3):138–145. doi: 10.1159/000214252. [DOI] [PubMed] [Google Scholar]
  6. GRAHAM R. C., Jr, EBERT R. H., RATNOFF O. D., MOSES J. M. PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ. J Exp Med. 1965 May 1;121:807–818. doi: 10.1084/jem.121.5.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Girolami A., Agostino D., Cliffton E. E. The effect of ellagic acid on coagulation in vivo. Blood. 1966 Jan;27(1):93–102. [PubMed] [Google Scholar]
  8. Glenn F. Acute acalculous cholecystitis. Ann Surg. 1979 Apr;189(4):458–465. [PMC free article] [PubMed] [Google Scholar]
  9. KOVALCIK V. THE RESPONSE OF THE ISOLATED DUCTUS ARTERIOSUS TO OXYGEN AND ANOXIA. J Physiol. 1963 Nov;169:185–197. doi: 10.1113/jphysiol.1963.sp007249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaplan A. P., Kay A. B., Austen K. F. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan;135(1):81–97. doi: 10.1084/jem.135.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kilburn K. H., Lynn W. S., Tres L. L., McKenzie W. N. Leukocyte recruitment through airway walls by condensed vegetable tannins and quercetin. Lab Invest. 1973 Jan;28(1):55–59. [PubMed] [Google Scholar]
  12. Majno G., Shea S. M., Leventhal M. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol. 1969 Sep;42(3):647–672. doi: 10.1083/jcb.42.3.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mandle R., Jr, Kaplan A. P. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977 Sep 10;252(17):6097–6104. [PubMed] [Google Scholar]
  14. Mann F. C. THE PRODUCTION BY CHEMICAL MEANS OF A SPECIFIC CHOLECYSTITIS. Ann Surg. 1921 Jan;73(1):54–57. doi: 10.1097/00000658-192101000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morrison D. C., Cochrane C. G. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med. 1974 Sep 1;140(3):797–811. doi: 10.1084/jem.140.3.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nakahara M. Activation of dog plasma kininogenase with glass. Biochem Pharmacol. 1974 Nov 1;23(21):3009–3015. doi: 10.1016/0006-2952(74)90276-7. [DOI] [PubMed] [Google Scholar]
  17. Ogston D., Bennett N. B., Ogston C. M., Ratnoff O. D. The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol. 1971 Feb;20(2):209–216. doi: 10.1111/j.1365-2141.1971.tb07029.x. [DOI] [PubMed] [Google Scholar]
  18. RATNOFF O. D., CRUM J. D. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. J Lab Clin Med. 1964 Mar;63:359–377. [PubMed] [Google Scholar]
  19. Ratnoff O. D., Naff G. B. The conversion of C'IS to C'1 esterase by plasmin and trypsin. J Exp Med. 1967 Feb 1;125(2):337–358. doi: 10.1084/jem.125.2.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Saito H., Goldsmith G., Ratnoff O. D. Fletcher factor activity in plasmas of various species. Proc Soc Exp Biol Med. 1974 Nov;147(2):519–523. doi: 10.3181/00379727-147-38378. [DOI] [PubMed] [Google Scholar]
  21. Wilner G. D., Nossel H. L., LeRoy E. C. Activation of Hageman factor by collagen. J Clin Invest. 1968 Dec;47(12):2608–2615. doi: 10.1172/JCI105943. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES